The mechanism of dorzagliatin is to repair the first stage of insulin secretion and improve glucose‐stimulated secretion of GLP‐1 in patients suffering from diabetes through allosteric regulation of GK activity,79, 80 which can accelerate the synthesis of glycogen in the liver and reduce the output of liver glucose in diabetic patients. The gene discussed is INS; the disease is diabetes mellitus.